Rey Jean M.

Garcia BSN3-C

DRUG STUDY

Name of Classification Mechanism of Indication Adverse Effects Nursing Patient Teaching

Generic: Pharmacologic Inhibits Bradyarrhythmias, CNS: headache, Watch closely for Instruct patient
class: acetylcholine at symptomatic restlessness, ataxia, signs and to immediately
Atropine Anticholinergic parasympa- thetic bradycardia disorientation, delirium,
symptoms of report allergic
sulfate insomnia, dizziness,
(antimuscarinic) neuroeffector drowsiness, agitation, anaphylaxis. response.
junction of smooth nervousness, confusion,
Dosage: Therapeutic muscle and excitement Monitor heart rate Inform patient
class: cardiac muscle, for bradycardia or that headache,
1mg/ml Antiarrhythmic blocking sinoatrial CV: palpitations, tachycardia. eye pain, and
(SA) and atrioven- bradycardia, tachycardia Evaluate fluid blurred vision
tricular (AV) intake and output. may signal
EENT: photophobia,
nodes. These blurred vision, increased
glaucoma. Tell
actions increase intraocular pressure, Assess for urine him to report
impulse mydriasis, cycloplegia, retention or urinary these symptoms
conduction and nasal congestion hesitancy. at once.
raise heart rate. In
ophthalmic use, GI: nausea, vomiting, Monitor for signs Caution patient
blocks cholinergic constipation, bloating, and symptoms of to avoid
dyspepsia, ileus,
stimulation to iris abdominal distention (in
glaucoma. hazardous
and cil- iary infants), dysphagia, dry activities until
bodies, causing mouth he/she knows
pupillary dilation how drug affects
and GU: urinary retention, concentration,
accommodation urinary hesitancy, alertness, and
paralysis. impotence vision.
Skin: decreased
sweating, flushing,
urticaria, dry skin

Other: thirst, anaphylaxis

DRUG STUDY

Name of Classification Mechanism of Indication Adverse Effects Nursing Consideration Patient Teaching
Drug Action

Generic: Pharmacologic Increases force Heart failure; CNS: fatigue, Assess apical pulse Tell patient to take
class: Cardiac and velocity of tachyarrhythmias; headache, regularly for 1 full drug at same time
Digoxin glycoside myocardial atrial fibrillation asthenia minute. If rate is less every day.
contraction and and flutter; than 60 beats/ minute,
Dosage: Therapeutic prolongs paroxysmal atrial CV: bradycardia, withhold dose and Instruct patient not
class: refractory period tachycardia ECG changes, notify prescriber. to stop drug
0.5mg/2 ml Inotropic, anti- of arrhythmias abruptly.
arrhythmic atrioventricular Monitor for signs and
(AV) node by EENT: blurred or symptoms of drug Instruct patient not
increasing yellow vision toxicity (such as to take over-the-
calcium entry nausea, vomiting, counter drugs
into myocardial GI: nausea, visual disturbances, without prescriber’s
cells. Slows vomiting, diarrhea arrhythmias, and approval.
conduction altered mental status).
through GU: gynecomastia Teach patient how
sinoatrial and Hematologic: Monitor ECG and to recognize and
AV nodes and thrombocytopenia blood levels of digoxin, report signs and
produces potassium, symptoms of
antiarrhythmic Other: decreased magnesium, calcium, digoxin toxicity.
effect. appetite and creatinine.
Tell the importance
Stay alert for of follow-up testing
hypocalcemia. Know as directed by
that this condition may prescriber.
predispose patient to
digoxin toxicity and
may decrease digoxin
efficacy.
References: Schull, P. D., McGraw-Hill Nurse’s Drug handbook 7 th Edition
Rey Jean M. Garcia BSN3-C